Trevi Therapeutics Correlations

TRVI Stock

USD 2.91 0.18 6.59%

The current 90-days correlation between Trevi Therapeutics and ATyr Pharma is -0.12 (i.e., Good diversification). The correlation of Trevi Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Trevi Therapeutics Correlation With Market

Weak diversification

The correlation between Trevi Therapeutics and DJI is 0.36 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trevi Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.

Moving together with Trevi Stock

0.67	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	TIL	Instil Bio	Pair Corr
0.66	INZY	Inozyme Pharma	Pair Corr
0.67	PCVX	Vaxcyte	Pair Corr
0.64	PHAT	Phathom Pharmaceuticals	Pair Corr

Moving against Trevi Stock

0.5	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.51	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.44	RVMD	Revolution Medicines Sell-off Trend	Pair Corr
0.4	MNPR	Monopar Therapeutics	Pair Corr

Related Correlations Analysis

	LIFE	CUE	ANTX	BCAB	SPRO	BOLT	CHRS	GRCL	NLTX	FHTX
LIFE		-0.03	-0.54	0.18	0.35	0.25	-0.02	-0.21	0.5	0.24	LIFE
CUE	-0.03		0.08	0.59	-0.37	0.14	-0.77	0.77	-0.41	-0.35	CUE
ANTX	-0.54	0.08		-0.19	-0.1	0.0	0.18	0.0	-0.47	-0.16	ANTX
BCAB	0.18	0.59	-0.19		0.18	0.55	-0.32	0.27	0.02	-0.17	BCAB
SPRO	0.35	-0.37	-0.1	0.18		0.62	0.54	-0.62	0.61	0.44	SPRO
BOLT	0.25	0.14	0.0	0.55	0.62		0.23	-0.27	0.23	-0.21	BOLT
CHRS	-0.02	-0.77	0.18	-0.32	0.54	0.23		-0.8	0.36	0.07	CHRS
GRCL	-0.21	0.77	0.0	0.27	-0.62	-0.27	-0.8		-0.61	-0.31	GRCL
NLTX	0.5	-0.41	-0.47	0.02	0.61	0.23	0.36	-0.61		0.57	NLTX
FHTX	0.24	-0.35	-0.16	-0.17	0.44	-0.21	0.07	-0.31	0.57		FHTX
	LIFE	CUE	ANTX	BCAB	SPRO	BOLT	CHRS	GRCL	NLTX	FHTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

GRCL	+ 0.77	CUE
BOLT	+ 0.62	SPRO
NLTX	+ 0.61	SPRO
BCAB	+ 0.59	CUE
FHTX	+ 0.57	NLTX
BOLT	+ 0.55	BCAB

High negative correlations

GRCL	- 0.8	CHRS
CHRS	- 0.77	CUE
GRCL	- 0.62	SPRO
NLTX	- 0.61	GRCL
ANTX	- 0.54	LIFE
NLTX	- 0.47	ANTX

Risk-Adjusted Indicators

There is a big difference between Trevi Stock performing well and Trevi Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Trevi Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIFE	2.57	0.46	0.09	(0.82)	2.62	(3.23)	6.45	(5.29)	28.98
CUE	7.51	0.80	0.12	1.05	5.93	(12.72)	20.27	(11.51)	67.78
ANTX	1.90	0.25	0.08	0.47	1.86	(3.07)	3.64	(3.42)	28.03
BCAB	4.31	(0.24)	0.00	(0.03)	0.00	0.00	12.86	(7.59)	31.41
SPRO	1.78	(0.27)	0.00	(0.41)	0.00	0.00	3.79	(4.58)	14.92
BOLT	1.69	(0.25)	0.00	(2.95)	0.00	0.00	4.76	(4.48)	14.96
CHRS	4.02	(0.19)	0.00	(0.16)	0.00	0.00	7.62	(6.94)	34.15
GRCL	5.71	1.25	0.18	1.02	6.35	(6.70)	16.34	(6.25)	52.11
NLTX	2.25	(0.22)	0.00	(0.55)	0.00	0.00	4.05	(3.53)	27.84
FHTX	4.06	(0.21)	0.02	0.06	4.43	(4.53)	8.50	(6.81)	34.64

Trevi Therapeutics Corporate Management

Farrell PharmD	Chief Officer	Profile
Christopher Galletta	Controller Officer	Profile
AFPM MD	Chief Officer	Profile
Danine Summers	Vice Affairs	Profile
Lisa Delfini	Chief Officer	Profile
Jennifer Good	CEO, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC